Unverified50% confidenceOpinionExact time
For eating disorder patients with comorbid obesity, GLP-1 drugs may help control weight-related health risks.
1
Sources
50%
Confidence
Long-term
Relevance
10/30/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedThe reason for weight rebound after discontinuing GLP-1 drugs is that they do not fundamentally alter the metabolic set point, and after stopping the drugs the body drives weight regain through increased hunger and reduced metabolic rate.77% similarUnverifiedWhen using GLP-1 drugs for weight loss, approximately one-third of the weight lost is lean body mass, primarily muscle, and may also include some bone mass.74% similarUnverifiedInterdisciplinary collaboration—including endocrinology, psychiatry, nutrition, and public health—is key to reducing the risk of eating disorders associated with GLP-1 drugs.73% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1115046API
curl https://kongchang.com/api/v1/knowledge/claims/1115046MCP
get_claim(id=1115046)